Central Pulse Pressure and Mortality in End-Stage Renal Disease
By M. Safar, J. Blacher, B. Pannier, A. Guérin, S. Marchais, P. Guyonvarc’h, G. London. HYPERTENSION, 2002
847 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/3ea7b0a8aa928abb3805bcd30180dc1a76b8cf21
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
- Michael F. O'Rourke
- Philippe van de Borne
- I. Wilkinson
- J. Cockcroft
- S. Laurent
- E. Schiffrin
- H. S. Boudier
- Massimo F. Piepoli
In Pulmonary and Respiratory Medicine
Citations in the corpus
- Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo-Cardiff Collaborative Trial (ACCT). (2005, background): “In contrast, central PP increased linearly with age, which might have important clinical implications, because recent data suggest that central PP might provide a better marker of cardiovascular risk than peripheral values do ( 20 ).”
- Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis. (2010, background): “ESRD (n 1⁄4 180) 54+ 16 60 52+ 36 m 70 deaths; 40 CV deaths Carotid AIx Tonometry of CCA 0% Continuous; quartiles; optimal cut-off by ROC curve Age, sex, diastolic BP, HR, smoking, duration of dialysis, blood chemistry analyses, ACE-inhibitor prescription, PWV Safar et al.(15) ESRD (n 1⁄4 180) 54+ 1”
- 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) (2007, background): “Early epidemiological studies in the 2000s showed that central augmentation index and pulse pressure, directly measured by carotid tonometry, were independent predictors of all-cause and CV mortality in patients with ESRD [139].”